| scholarly article | Q13442814 |
| P50 | author | Philip L Gordts | Q59696191 |
| Maura Poli | Q91811023 | ||
| Jeffrey Esko | Q15989713 | ||
| P2093 | author name string | Paolo Arosio | |
| Andrea Denardo | |||
| Magdalena Gryzik | |||
| Michela Asperti | |||
| Ferdous Anower-E-Khuda | |||
| Paola Ruzzenenti | |||
| P2860 | cites work | Heparin, Heparan Sulphate and the TGF-β Cytokine Superfamily | Q38688063 |
| Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia. | Q39233824 | ||
| A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells | Q39990819 | ||
| BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism | Q41871982 | ||
| Iron overload induces BMP6 expression in the liver but not in the duodenum. | Q42586767 | ||
| Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo | Q45896455 | ||
| Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans | Q46459499 | ||
| Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses | Q46806608 | ||
| Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway | Q47781819 | ||
| Comparison of 3 Tfr2-deficient murine models suggests distinct functions for Tfr2-alpha and Tfr2-beta isoforms in different tissues. | Q54440169 | ||
| Hepcidin regulation by innate immune and infectious stimuli | Q59401841 | ||
| Heparan sulfate structure in mice with genetically modified heparan sulfate production | Q80413581 | ||
| Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS | Q81734651 | ||
| Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo | Q85348566 | ||
| Domains with highest heparan sulfate-binding affinity reside at opposite ends in BMP2/4 versus BMP5/6/7: Implications for function | Q90784721 | ||
| Genome engineering using the CRISPR-Cas9 system | Q22122027 | ||
| Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization | Q24310115 | ||
| Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression | Q24316099 | ||
| Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin | Q24648028 | ||
| Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload? | Q27310179 | ||
| The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin | Q28115763 | ||
| Two to tango: regulation of Mammalian iron metabolism | Q28287034 | ||
| Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver | Q28506594 | ||
| Lack of the bone morphogenetic protein BMP6 induces massive iron overload | Q28510138 | ||
| A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression | Q28590840 | ||
| Heparan sulfate acts as a bone morphogenetic protein coreceptor by facilitating ligand-induced receptor hetero-oligomerization | Q30433400 | ||
| Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in mice | Q33587338 | ||
| Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice | Q33806074 | ||
| Chlorate--a potent inhibitor of protein sulfation in intact cells | Q34162808 | ||
| Impaired LDL receptor-related protein 1 translocation correlates with improved dyslipidemia and atherosclerosis in apoE-deficient mice | Q34305393 | ||
| Symbol Nomenclature for Graphical Representations of Glycans | Q34500799 | ||
| Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members | Q35250965 | ||
| Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance | Q35631767 | ||
| Heparanase Overexpression Reduces Hepcidin Expression, Affects Iron Homeostasis and Alters the Response to Inflammation | Q36155327 | ||
| Neogenin interacts with matriptase-2 to facilitate hemojuvelin cleavage | Q36318716 | ||
| Surfen, a small molecule antagonist of heparan sulfate | Q36861535 | ||
| Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling | Q36980992 | ||
| Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice | Q37292212 | ||
| Small molecule antagonists of cell-surface heparan sulfate and heparin-protein interactions. | Q37607660 | ||
| Glycol-split nonanticoagulant heparins are inhibitors of hepcidin expression in vitro and in vivo. | Q37623543 | ||
| Hepcidin and disorders of iron metabolism | Q37795819 | ||
| Demystifying heparan sulfate-protein interactions. | Q38194193 | ||
| High Sulfation and a High Molecular Weight Are Important for Anti-hepcidin Activity of Heparin. | Q38639564 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 36 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 13292-13303 | |
| P577 | publication date | 2019-07-17 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice | |
| P478 | volume | 294 |
| Q91762627 | Influence of Liver Fibrosis on Lobular Zonation | cites work | P2860 |
Search more.